CT-Luso Clinical Trials
Funding Entity Horizon (European Comission)
Financed Amount 997.513,75€
Consortium Ordem dos Farmacêuticos; Ministério da Saúde; BlueClinical; Centro de Direito Médico; FFUL; Infarmed; Instituto Nacional de Saúde Dr. Ricardo Jorge; Anarme;
Start date 2024-09-01
Final date 2027-12-30
Objective
CT-Luso is a Project for Ethical and Regulatory Capacity Building in Clinical Trials in Portuguese-speaking African Countries (PALOP) – Angola, Cape Verde, Guinea-Bissau, Mozambique, and São Tomé and Príncipe – in partnership with Portugal. It is approved and funded by the Europe and Developing Countries Partnership for Clinical Trials (EDCTP3) Program with support from the European Union (EU), running from September 1, 2024, to December 30, 2027.
This project was built as a continuation and ambitious development of the goals achieved by BERC-Luso, an Ethical and Regulatory Capacity Building Project in Portuguese-speaking African Countries, approved and funded by the EDCTP2 Program and the Calouste Gulbenkian Foundation, which ran from 2018 to 2022.